Rhenium Re‑186 is used to relieve bone pain from cancer metastases, especially in prostate and breast cancer. It’s also used in radiosynovectomy to treat joint inflammation in conditions like rheumatoid arthritis. The isotope delivers targeted beta radiation with minimal impact on healthy tissue. It is commonly administered as Re-186 HEDP or Re-186 sulfide colloid. It is grouped under the following drug class(es): Radiopharmaceuticals. The directory classifies it as a commercial API with a mineral/inorganic source/manufacturing origin. Other names for this substance include 186Re radioisotope, 186Re and ZU7F1ET6TM. Its PubChem CID is 161105.
Rhenium Re-186
| CAS No | 14998-63-1 |
|---|---|
| Molecular Formula | Re |
| Molecular Weight | 185.96 g/mol |
| Synonyms | rhenium-186 |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Rhenium Re‑186 is used to relieve bone pain from cancer metastases, especially in prostate and breast cancer. It’s also used in radiosynovectomy to treat joint inflammation in conditions like rheumatoid arthritis.
The listed CAS number is 14998-63-1.
The listed molecular formula is Re.
The listed molecular weight is 185.96 g/mol.
rhenium-186.
The source lists 186Re radioisotope, 186Re and ZU7F1ET6TM.